In contrast to the role of PD-L1 in immune evasion, RKIP’s emerging role as an immune modulator, regulating crucial pathways in immune surveillance and suppression, led us to propose that there exists—directly or indirectly—signaling cross-talks between RKIP and PD-L1 expressions in cancer cells. The gene discussed is PEBP1; the disease is cancer.